vs

Side-by-side financial comparison of ALEXANDERS INC (ALX) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

ALEXANDERS INC is the larger business by last-quarter revenue ($53.3M vs $40.7M, roughly 1.3× PETMED EXPRESS INC). On growth, ALEXANDERS INC posted the faster year-over-year revenue change (-4.7% vs -23.3%). Over the past eight quarters, ALEXANDERS INC's revenue compounded faster (-6.9% CAGR vs -20.9%).

Alexander's, Inc. is a real estate investment trust that owns 7 properties in New York metropolitan area, including 731 Lexington Avenue, the headquarters of Bloomberg L.P. It is controlled by Vornado Realty Trust. It was founded by George Farkas and Louis Schwadron in 1928.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

ALX vs PETS — Head-to-Head

Bigger by revenue
ALX
ALX
1.3× larger
ALX
$53.3M
$40.7M
PETS
Growing faster (revenue YoY)
ALX
ALX
+18.5% gap
ALX
-4.7%
-23.3%
PETS
Faster 2-yr revenue CAGR
ALX
ALX
Annualised
ALX
-6.9%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ALX
ALX
PETS
PETS
Revenue
$53.3M
$40.7M
Net Profit
$-10.6M
Gross Margin
23.3%
Operating Margin
-25.7%
Net Margin
-26.0%
Revenue YoY
-4.7%
-23.3%
Net Profit YoY
-1392.6%
EPS (diluted)
$0.75
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALX
ALX
PETS
PETS
Q4 25
$53.3M
$40.7M
Q3 25
$53.4M
$44.4M
Q2 25
$51.6M
$51.2M
Q1 25
$54.9M
$50.8M
Q4 24
$55.9M
$52.0M
Q3 24
$55.7M
$58.0M
Q2 24
$53.4M
$66.2M
Q1 24
$61.4M
$65.1M
Net Profit
ALX
ALX
PETS
PETS
Q4 25
$-10.6M
Q3 25
$6.0M
$-8.5M
Q2 25
$6.1M
$-34.2M
Q1 25
$12.3M
$-11.6M
Q4 24
$-707.0K
Q3 24
$6.7M
$2.3M
Q2 24
$8.4M
$3.8M
Q1 24
$16.1M
$-5.0M
Gross Margin
ALX
ALX
PETS
PETS
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
ALX
ALX
PETS
PETS
Q4 25
-25.7%
Q3 25
-18.9%
Q2 25
-66.7%
Q1 25
-11.9%
Q4 24
-0.9%
Q3 24
1.0%
Q2 24
6.6%
Q1 24
-5.9%
Net Margin
ALX
ALX
PETS
PETS
Q4 25
-26.0%
Q3 25
11.2%
-19.2%
Q2 25
11.9%
-66.7%
Q1 25
22.4%
-22.9%
Q4 24
-1.4%
Q3 24
12.0%
4.0%
Q2 24
15.7%
5.7%
Q1 24
26.2%
-7.7%
EPS (diluted)
ALX
ALX
PETS
PETS
Q4 25
$0.75
$-0.50
Q3 25
$1.16
$-0.41
Q2 25
$1.19
$-1.65
Q1 25
$2.40
$-0.56
Q4 24
$2.39
$-0.03
Q3 24
$1.30
$0.11
Q2 24
$1.63
$0.18
Q1 24
$3.14
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALX
ALX
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$128.2M
$26.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$109.2M
$32.8M
Total Assets
$1.1B
$88.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALX
ALX
PETS
PETS
Q4 25
$128.2M
$26.9M
Q3 25
$286.1M
$36.1M
Q2 25
$313.0M
$41.1M
Q1 25
$319.9M
$54.7M
Q4 24
$338.5M
$50.1M
Q3 24
$354.8M
$52.0M
Q2 24
$410.9M
$46.0M
Q1 24
$526.3M
$55.3M
Stockholders' Equity
ALX
ALX
PETS
PETS
Q4 25
$109.2M
$32.8M
Q3 25
$128.3M
$43.1M
Q2 25
$145.4M
$51.5M
Q1 25
$163.1M
$85.1M
Q4 24
$176.9M
$96.2M
Q3 24
$190.7M
$96.4M
Q2 24
$212.5M
$93.5M
Q1 24
$230.1M
$96.7M
Total Assets
ALX
ALX
PETS
PETS
Q4 25
$1.1B
$88.0M
Q3 25
$1.3B
$100.3M
Q2 25
$1.3B
$109.8M
Q1 25
$1.3B
$148.7M
Q4 24
$1.3B
$144.8M
Q3 24
$1.4B
$146.0M
Q2 24
$1.5B
$152.7M
Q1 24
$1.4B
$169.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALX
ALX
PETS
PETS
Operating Cash FlowLast quarter
$73.4M
$-9.2M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALX
ALX
PETS
PETS
Q4 25
$73.4M
$-9.2M
Q3 25
$-9.3M
$-2.2M
Q2 25
$43.6M
$-12.3M
Q1 25
$15.7M
$7.0M
Q4 24
$54.1M
$-1.2M
Q3 24
$-5.0M
$7.4M
Q2 24
$11.5M
$-8.5M
Q1 24
$16.8M
$7.1M
Free Cash Flow
ALX
ALX
PETS
PETS
Q4 25
$-9.2M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$-1.9M
Q3 24
$6.1M
Q2 24
$-9.2M
Q1 24
$5.9M
FCF Margin
ALX
ALX
PETS
PETS
Q4 25
-22.7%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
-3.7%
Q3 24
10.6%
Q2 24
-13.9%
Q1 24
9.0%
Capex Intensity
ALX
ALX
PETS
PETS
Q4 25
0.1%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
1.5%
Q3 24
2.2%
Q2 24
1.0%
Q1 24
1.9%
Cash Conversion
ALX
ALX
PETS
PETS
Q4 25
Q3 25
-1.55×
Q2 25
7.12×
Q1 25
1.28×
Q4 24
Q3 24
-0.75×
3.18×
Q2 24
1.37×
-2.27×
Q1 24
1.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALX
ALX

Segment breakdown not available.

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons